Patent Document ID: 20140341858
Application ID: 14312048
Patent Flag: 0

Claim One:
1. A product, which is: a polypeptide, wherein the sequence of said polypeptide consists of less than 100 amino acids, wherein said sequence of less than 100 amino acids comprises a sequence consisting of, in N- to C-terminal orientation: the sequence of the signal peptide of the G protein of a rabies virus strain, the sequence of a fragment of the ectodomain of the G protein of a rabies virus strain, and the sequence of the transmembrane domain of the G protein of a rabies virus strain, and wherein said sequence of less than 100 amino acids further comprises: i. the sequence of SEQ ID NO: 6, or ii. a sequence, which: is of 34 to 54 amino acids, is at least 94% identical to said sequence of SEQ ID NO: 6 over the entire length of the shortest of the two sequences, comprises a PDZ-BS sequence, wherein said PDZ-BS sequence is: x 1 is Q, and x 2 is T or S or I, and x 3 is any amino acid, and x 4 is L or V (SEQ ID NO: 14), said sequence being referred to as variant sequence A, or iii. a sequence, which: is of 44 amino acids, is at least 94% identical to said sequence of SEQ ID NO: 6, comprises a PDZ-BS sequence, wherein said PDZ-BS sequence is: x 1 is E, and x 2 is T or S or I, and x 3 is any amino acid, and x 4 is L or V (SEQ ID NO: 13 with x 1 =E), and does not comprise the amino acid L at position 11, said sequence being referred to as variant sequence B, or iv. a fragment of said sequence of SEQ ID NO: 6 or of said variant sequence A or of said variant sequence B, wherein said fragment is of at least 34 amino acids and has retained the PDZ-BS sequence of said sequence of SEQ ID NO: 6 or of said variant sequence A or of said variant sequence B, respectively, or a cell comprising said polypeptide, or a composition or a drug or a pharmaceutical composition, comprising said polypeptide and/or said cell.